SEC Tracker
Get the app

Alector ALEC

Neil Lindsay Berkley insider sold shares

Neil Lindsay Berkley, insider filing for ALEC

Form
4
Filed
Importance
Routine
  1. Oct 14, 2026 - 44,567 shares sold
  2. Oct 14, 2026 - 190,000 options exercised
  3. CFO & Chief Business Officer - Neil Lindsay Berkley

Written from the Form 4 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Alector files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Protalix BioTherapeutics PLX public float $113M, Jun 30, 2025
  2. Fate Therapeutics FATE public float $113M, Jun 30, 2025
  3. Caribou Biosciences CRBU public float $113M, Jun 30, 2025
  4. Protara Therapeutics PRTO public float $112M, Jun 30, 2025
  5. TuHURA Biosciences HURA public float $111M, Jun 30, 2025